SACHS BRUCE I 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Aug 2, 2024
Insider Transaction Report
Form 4
SACHS BRUCE I
Director
Transactions
- Sale
Common Stock
2024-08-01$508.00/sh−5,295$2,689,860→ 40,000 total - Exercise/Conversion
Common Stock
2024-08-01$125.71/sh+5,295$665,634→ 45,295 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-01−5,295→ 0 totalExercise: $125.71Exp: 2027-05-31→ Common Stock (5,295 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 02/12/2024.
- [F2]Fully vested.